A detailed history of Seven Eight Capital, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 199,934 shares of BBIO stock, worth $5.7 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
199,934
Holding current value
$5.7 Million
% of portfolio
0.48%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.91 - $31.3 $4.78 Million - $6.26 Million
199,934 New
199,934 $5.09 Million
Q1 2022

May 11, 2022

SELL
$7.34 - $17.16 $1.56 Million - $3.66 Million
-213,121 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $2.43 Million - $11.4 Million
213,121 New
213,121 $3.56 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.